Close Menu

NEW YORK – The Association for Molecular Pathology released preliminary survey results on Tuesday showing that molecular testing for cancer declined significantly during the COVID-19 pandemic.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.